Total Payments
$1,986
2024 Payments
$1,229
Companies
25
Transactions
107
Medicare Patients
1,320
Medicare Billing
$190,226
Payment Breakdown by Category
Food & Beverage$1,986 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,986 | 107 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $321.75 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $303.50 | 14 | $0 (2024) |
| ABBVIE INC. | $209.56 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $139.58 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $107.10 | 5 | $0 (2021) |
| Lilly USA, LLC | $106.32 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $106.18 | 5 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $80.48 | 4 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $79.87 | 4 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $74.83 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,229 | 67 | Novo Nordisk Inc ($289.48) |
| 2023 | $464.07 | 24 | AstraZeneca Pharmaceuticals LP ($136.21) |
| 2021 | $292.58 | 16 | SUN PHARMACEUTICAL INDUSTRIES INC. ($107.10) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Respiratory | ||||||
| 11/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Obesity | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: Obesity | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: DIABETES | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 361 | 917 | $110,769 | $44,439 |
| 2021 | 14 | 757 | 2,021 | $277,943 | $120,741 |
| 2020 | 5 | 202 | 465 | $61,332 | $25,046 |
Total Patients
1,320
Total Services
3,403
Medicare Billing
$190,226
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 185 | 561 | $67,320 | $27,423 | 40.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 114 | $14,250 | $6,099 | 42.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 53 | 85 | $12,155 | $5,730 | 47.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 72 | 133 | $13,300 | $4,077 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $3,744 | $1,111 | 29.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 179 | 733 | $95,290 | $39,157 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 542 | $70,065 | $29,582 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 100 | $19,545 | $9,833 | 50.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 103 | 158 | $18,980 | $8,475 | 44.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 78 | 113 | $16,950 | $8,020 | 47.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 104 | $16,224 | $7,233 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $6,000 | $3,331 | 55.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 18 | $5,160 | $3,020 | 58.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 21 | $5,460 | $2,759 | 50.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 30 | $4,800 | $2,355 | 49.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 19 | 56 | $5,380 | $1,630 | 30.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 40 | 44 | $4,840 | $1,405 | 29.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 17 | 19 | $2,724 | $1,348 | 49.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,925 | $1,172 | 40.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 15 | $1,560 | $692.70 | 44.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 14 | 14 | $1,400 | $478.24 | 34.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 14 | 14 | $640.00 | $248.92 | 38.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 102 | 243 | $31,590 | $13,273 | 42.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 119 | $15,470 | $6,654 | 43.0% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 41 | 56 | $6,160 | $1,939 | 31.5% |
About Chrystal Joy Jurado
Chrystal Joy Jurado is a Gerontology healthcare provider based in Hayward, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2020. The National Provider Identifier (NPI) number assigned to this provider is 1023635513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chrystal Joy Jurado has received a total of $1,986 in payments from pharmaceutical and medical device companies, with $1,229 received in 2024. These payments were reported across 107 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,986).
As a Medicare-enrolled provider, Jurado has provided services to 1,320 Medicare beneficiaries, totaling 3,403 services with total Medicare billing of $190,226. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gerontology
- Other Specialties Primary Care
- Location Hayward, CA
- Active Since 06/30/2020
- Last Updated 08/20/2020
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1023635513
Products in Payments
- VRAYLAR (Drug) $164.50
- Ozempic (Drug) $142.60
- AIRSUPRA (Drug) $121.24
- BREZTRI (Drug) $117.56
- XIFAXAN (Drug) $106.18
- Wegovy (Drug) $98.17
- REXULTI (Drug) $96.47
- MOUNJARO (Drug) $92.13
- KAPSPARGO (Drug) $85.19
- QUVIVIQ (Drug) $80.48
- Belbuca (Drug) $79.87
- CAPLYTA (Drug) $74.83
- LOKELMA (Drug) $46.05
- QULIPTA (Drug) $45.06
- ZTLido (Drug) $38.23
- JARDIANCE (Drug) $35.76
- Rybelsus (Drug) $34.67
- FANAPT (Drug) $33.46
- GARDASIL (Biological) $29.97
- AREXVY (Drug) $29.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.